Search details
1.
Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.
Clin Drug Investig
; 29(12): 757-65, 2009.
Article
in English
| MEDLINE | ID: mdl-19888782
Results
1 -
1
de 1
1
Next >
>>